Market Size 2023 (Base Year) | USD 22.84 Billion |
Market Size 2032 (Forecast Year) | USD 160.38 Billion |
CAGR | 24.18% |
Forecast Period | 2024 - 2032 |
Historical Period | 2018 - 2023 |
According to Market Research Store, the global legalized cannabis market size was valued at around USD 22.84 billion in 2023 and is estimated to reach USD 160.38 billion by 2032, to register a CAGR of approximately 24.18% in terms of revenue during the forecast period 2024-2032.
The legalized cannabis report provides a comprehensive analysis of the market, including its size, share, growth trends, revenue details, and other crucial information regarding the target market. It also covers the drivers, restraints, opportunities, and challenges till 2032.
Global Legalized Cannabis Market: Overview
Legalized Cannabis Market refers to the commercial production, distribution, and sale of cannabis for medical, recreational, and industrial purposes in regions where its use has been legalized. This market includes various cannabis products such as dried flower, edibles, oils, tinctures, and concentrates, along with ancillary products like vape pens, pipes, and other paraphernalia. The legalization of cannabis has spurred the growth of a dynamic market, with both medical and recreational cannabis sectors seeing significant expansion.
Key drivers for the market include the increasing acceptance of cannabis for medicinal use, with cannabis being utilized for pain relief, anxiety, and various chronic conditions. The growing recreational market, particularly in North America and Europe, is also a significant driver. Legalization initiatives, government regulations, and the expansion of retail distribution networks contribute to the growth of the industry. Companies are investing heavily in research and development to create innovative products and expand their market share.
Key Highlights
Legalized Cannabis Market: Dynamics
Key Drivers
Restraints
Opportunities
Challenges
Report Attributes | Report Details |
---|---|
Report Name | Legalized Cannabis Market |
Market Size in 2023 | USD 22.84 Billion |
Market Forecast in 2032 | USD 160.38 Billion |
Growth Rate | CAGR of 24.18% |
Number of Pages | 140 |
Key Companies Covered | Canopy Growth Corporation, GW Pharmaceuticals, plc, Aurora Cannabis Inc., Aphria Inc., Cronos Group, Tilray, Sundial Growers Inc., Insys Therapeutics Inc., The Scotts Company LLC, VIVO Cannabis Inc., Cara Therapeutics Inc. |
Segments Covered | By Product Type, By Application, and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2023 |
Forecast Year | 2024 to 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Legalized Cannabis Market: Segmentation Insights
The global legalized cannabis market is divided by product, application, and region.
Segmentation Insights by Product
Based on Product, the global legalized cannabis market is divided into cannabis herb, cannabis resin, and other.
Cannabis Herb segment remains the dominant product type in the legalized cannabis market due to its long-standing popularity, ease of access, and versatility in use. Cannabis resin is gaining popularity among consumers seeking higher potency cannabis products. As consumers become more knowledgeable about cannabis, there is a growing preference for concentrated products, especially for medicinal use.
Cannabis Herb refers to the dried flowers and leaves of the cannabis plant, which can be consumed through smoking, vaporizing, or used as an ingredient in various cannabis-infused products. The demand for cannabis herb is driven by the legalization of cannabis for both medical and recreational use across various regions. Cannabis herb is preferred for its traditional consumption method and high versatility in production.
Segmentation Insights by Application
On the basis of Application, the global legalized cannabis market is bifurcated into medical institutions, entertainment venue, and other.
Medical Institutions segment is expected to dominate the legalized cannabis market due to the growing recognition of cannabis as a viable therapeutic option for various medical conditions. The demand for medical cannabis is increasing as more studies highlight its potential therapeutic benefits. With growing acceptance and legalization of medical cannabis, more patients are turning to cannabis-based treatments, and medical institutions are incorporating cannabis into treatment regimens.
Entertainment Venues refer to places where cannabis is consumed for recreational purposes, including dispensaries, lounges, cannabis cafes, festivals, and events. The demand for cannabis in entertainment venues is growing as cannabis is legalized for recreational use in many regions. These venues are becoming a hub for consumers to socialize and experience cannabis in a safe and legal setting.
Legalized Cannabis Market: Regional Insights
North America, particularly the United States and Canada, is the largest and most developed market for legalized cannabis. In the U.S., states like California, Colorado, and Oregon have legalized recreational cannabis, and medical cannabis is legal in many others. Canada's nationwide legalization of recreational cannabis in 2018 has also made it a significant player in the market. The increasing number of dispensaries, growing consumer base, and the establishment of both medical and recreational cannabis markets contribute to North America's dominance in the global cannabis industry.
Europe is an emerging market for legalized cannabis, with several countries such as Germany, the UK, and the Netherlands leading the way. Germany, in particular, has a well-established medical cannabis market, and many other European countries are beginning to loosen their cannabis regulations. The region is witnessing a growing interest in medical cannabis products, especially for conditions like chronic pain and epilepsy. Several European countries are also exploring the possibility of recreational cannabis legalization, which is expected to fuel market growth in the coming years.
Asia-Pacific region is currently a smaller player in the legalized cannabis market, but it is expected to grow steadily in the coming years. Countries like Thailand and South Korea have made significant strides in legalizing medical cannabis, and other nations, such as Japan and Australia, are showing increased interest in cannabis for medical purposes. Australia, in particular, has established a legal framework for medical cannabis, and its market is expected to expand as demand grows. However, recreational cannabis remains largely illegal in most of the region, limiting the scope of the market for now.
Latin America is one of the fastest-growing markets for legalized cannabis, driven by shifting regulatory frameworks and increasing adoption of medical cannabis. Uruguay was the first country to fully legalize cannabis for both medical and recreational use in 2013, and other countries like Colombia and Mexico have made significant strides in medical cannabis legalization. As more nations in the region adopt pro-cannabis policies, Latin America is expected to become a significant player in the global cannabis market, particularly in terms of production and exports.
Middle East and Africa region is less developed in terms of cannabis legalization, with only a few countries like South Africa and Israel leading the way in terms of medical cannabis legalization. Israel is known for its extensive research on medical cannabis, and South Africa's constitutional court ruling in 2018 decriminalized the personal use of cannabis. However, the region's conservative stance on cannabis use means that the market remains relatively underdeveloped. As the global cannabis landscape evolves, some African nations may see opportunities for growth in both medical and recreational cannabis markets.
Legalized Cannabis Market: Competitive Landscape
The report provides an in-depth analysis of companies operating in the legalized cannabis market, including their geographic presence, business strategies, product offerings, market share, and recent developments. This analysis helps to understand market competition.
Some of the major players in the global legalized cannabis market include:
The global legalized cannabis market is segmented as follows:
By Product
By Application
By Region
Based on statistics from the Market Research Store, the global legalized cannabis market size was projected at approximately US$ 22.84 billion in 2023. Projections indicate that the market is expected to reach around US$ 160.38 billion in revenue by 2032.
The global legalized cannabis market is expected to grow at a Compound Annual Growth Rate (CAGR) of around 24.18% during the forecast period from 2024 to 2032.
North America is expected to dominate the global legalized cannabis market.
The global legalized cannabis market is driven by several factors, including changing public perceptions, evolving legal frameworks, and the increasing recognition of cannabis' potential medical benefits.
Some of the prominent players operating in the global legalized cannabis market are; ABcann Medicinals, ABcann Medicinals, Aphria, Aurora Cannabis, Canopy Growth, Cronos Group, Dixie Elixirs, Maricann Group, and others.
Legalized Cannabis
Legalized Cannabis
×